Cargando…
Mesenchymal stem cell extracellular vesicles-derived microRNA-194-5p delays the development of intervertebral disc degeneration by targeting TRAF6
OBJECTIVE: Mesenchymal stem cells-derived extracellular vesicles (MSCs-EVs) can improve intervertebral disc degeneration (IDD). Considering that, their concrete mechanisms from microRNA-194-5p/tumor receptor-associated factor 6 (miR-194-5p/TRAF6) axis in IDD ask for disclosure in a scientific way. M...
Autores principales: | Sun, Zhongyi, Tang, Xiaoming, Li, Qiuyuan, Wang, Haibin, Sun, Hongzhi, Tian, Jiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787669/ https://www.ncbi.nlm.nih.gov/pubmed/35127996 http://dx.doi.org/10.1016/j.reth.2021.12.001 |
Ejemplares similares
-
Extracellular Vesicles Derived From Stem Cells in Intervertebral Disc Degeneration
por: Wu, Xinjie, et al.
Publicado: (2022) -
Inflammatory microRNA-194 and -515 attenuate the biosynthesis of chondroitin sulfate during human intervertebral disc degeneration
por: Hu, Bo, et al.
Publicado: (2017) -
MicroRNA-194 Inhibits Lipopolysaccharide-Induced Inflammatory Response in Nucleus Pulposus Cells of the Intervertebral Disc by Targeting TNF Receptor-Associated Factor 6 (TRAF6)
por: Kong, Lili, et al.
Publicado: (2018) -
Platelet-derived extracellular vesicles ameliorate intervertebral disc degeneration by alleviating mitochondrial dysfunction
por: Dai, Zhanqiu, et al.
Publicado: (2022) -
The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment
por: Sun, Zhen, et al.
Publicado: (2020)